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Abstract The power of serum lathosterol concentration as an 
indicator of whole-body cholesterol synthesis was investigated in 
47 human volunteers consuming two diets differing in fatty acid 
composition. The cholesterol balance (fecal excretion of neutral 
and acid steroids minus cholesterol intake) was strongly cor- 
related with the serum level of total (free plus esterified) 
lathosterol and also with the ratio of serum lathosterol over 
serum cholesterol, both on a diet rich in polyunsaturated fatty 
acids (r  = 0.74 for the ratio) and one containing mainly satu- 
rated fatty acids (r = 0.70 for the ratio). In a subgroup for 
which the serum levels of free lanosterol and other free methyl- 
sterols were also quantitated, the correlations of these levels (ex- 
pressed relative to serum free cholesterol) with the cholesterol 
balance were lower than that found for total lathosterol (ex- 
pressed relative to serum total cholesterol). A further corrobora- 
tion was obtained by measuring the lathosterol/cholesterol ratio 
in 20 patients with familial hypercholesterolemia before and 
during treatment with the hydroxymethylglutaryl coenzyme A 
reductase inhibitor Mk-733. The ratio was lowered by 47% 
during drug treatment, suggesting a significant decrease of the 
cholesterol balance in these patients. We conclude, from the 
various indicators proposed to monitor whole-body cholesterol 
synthesis, that the lathosterol/cholesterol ratio in serum appears 
preferable with respect to indicative power and ease of quantita- 
tion. - Kempen, H. J. M., J. F. C. Glatz, J. A. Gevers Leuven, 
H. A. van der Voort, and M. B. Katan. Serum lathosterol con- 
centration is an indicator of whole-body cholesterol synthesis in 
humans. J.  Lipid Res. 1988. 29: 1149-1155. 
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The classical method of assessing the rate of whole- 
body cholesterol synthesis in humans, without resorting 
to the use of radioisotopes, comprises measurement of the 
cholesterol balance, i.e., fecal excretion of cholesterol plus 
its acidic (1) and neutral (2) metabolites, minus choles- 
terol intake. Although this method is well established, it 
has the disadvantage of being laborious and is not suited 
to detecting changes in cholesterol synthesis occurring 
within the time-scale of less than a few days. Moreover, 
the method requires that the subjects be in a steady state 
with regard to cholesterol metabolism. For these reasons, 
alternative methods have been sought to monitor whole- 
body cholesterol synthesis. Serum levels of various pre- 
cursors along the cholesterol synthesis pathway have been 
proposed for that purpose, namely (in historical order) 
free methylsterols (3-5), squalene (3, 6 ,  7), and mevalonic 
acid (8,9). Levels of these precursors were shown t o  corre- 
late significantly with the cholesterol balance in condi- 
tions with greatly varying rates of cholesterol synthesis 
and to fluctuate with a diurnal rhythm (4, 5, 9, 10). 
Plasma squalene, however, has now been established to 
reflect the plasma VLDL concentration rather than the 
rate of whole-body cholesterol synthesis (11, 12). 
Miettinen (13) and Vuoristo and Miettinen (14) reported 
recently that the serum level of 7-lathosterol (5a-cholest-7- 
ene-36-01) in humans decreased upon expansion and in- 
creased upon depletion of the bile acids pool, in a more 
pronounced way than free methylsterols. We have inveati- 
gated whether the serum level of lathosterol was cor- 
related with the cholesterol balance in healthy volunteers 
on two controlled diets. The study was originally designed 
to assess the effect of a change in dietary fatty acid compo- 
sition on cholesterol synthesis. The specific effects in- 
duced by the diet change will be reported extensively 
elsewhere. Here we wish to report that the ratio of 
serum lathosterol over serum cholesterol strongly corre- 
lates with the cholesterol balance under both dietary con- 
ditions. Moreover, this ratio fell in patients with familial 
hypercholesterolemia during treatment with a potent 
HMG-CoA reductase inhibitor. 
Abbreviations: HMG-CoA, 3-hydroxy-3-methylglutaryl coenzyme A; 
ACAT, acylcoenzyme A:cholesteroI acyltransferase; LCAT, 1ecithin:cho- 
lesterol acyltransferase. 
'Portions of these data were presented during the 9th Conference on 
Drugs Affecting Lipid Metabolism, Florence, Italy, October 1986. 
*To whom correspondence should be addressed. 
3Present address: Department of Physiology, University of Limburg, 
P.O. Box 616, 6200 M D  Maastricht, The Netherlands. 
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MATERIALS AND METHODS TABLE 1 .  Mean daily nutrient intake of the 47 subjects during thv 
two dietary periods, according to duplicate portion analysis" 
Nutricni High PIS diet Low PIS dit1 Subjects and treatments 
11.6 11.5 
healthy volunteers living in or around Wageningen, who protein (en %) 13.2 14.2 
design of the study. They formed a composite of one Saturated (en W) 10.6 23.4 
Monounsaturated (en W) 1 1 . 7  14.3 
group of 23 and another of 24 subjects. Group 1 consisted Polyunsaturated (en %) 20.8 5.2 
(MJ) 
The first part of the study was carried out with 47 
Total energy6 
participated after being informed about the purpose and Fat (en %) 45.0 44.5 
of 14 men and 9 women, most of them students and uni- Carbohydrates (en %) 39.9 39.4 
versity staff. All had participated in three previous con- *lcohol (en %) 2.0 2.0 
trolled dietary trials (15, 16). Their characteristics at entry Cholestero1 (mdday) 483 456 
weight 11.4 f 9.5 kg, and body mass index 22.5 + 2.2 Sitosterol (mg/day) 369 153 
kg/m2. Group 2 consisted of 10 men and 14 women with Unidentiiied stero1s fmdday)  277 103 
a high habitual consumption of eggs. All of them had par- 
ticipated earlier in two outpatient trials on the effect of 
dietary cholesterol on serum lipids (17, 18), and six had 
participated in a third controlled trial (19). Their charac- 
teristics at entry into the trial were: age 54 k 13 yr, height 
172 k 7 cm, weight 73.7 k 15.2 and body mass index 
24.4 k 2.8 kg/m2. 
The baseline levels of serum total cholesterol, HDL 
cholesterol, and triglycerides for these 47 subjects were 
5.66 f 1.21, 1.42 t 0.32, and 1.32 k 0.75 mmol/L, freeze-dried, and again stored at -2OOC. 
respectively, determined in fasting blood samples taken 
2-4 weeks before starting the experiment. 
The subjects in Group 1 first received a mixed natural 
diet that was high in polyunsaturated and low in saturated 
fatty acids for 3 weeks (high P/S diet), and then changed 
to a diet rich in saturated and poor in polyunsaturated 
fatty acids for another 3 weeks (low P/S diet). For the sub- 
jects in Group 2 the order of these diets was reversed. The 
intake of total fat and of cholesterol did not change from 
one dietary period to another. The diets were prepared 
and supplied at the Department of Human Nutrition as 
described (20). Nutrient and sterol compositions of the 
diets were assessed by analysis of duplicate portions for 
one imaginary person of average energy intake on each 
diet. These compositions are given in Table 1. The food 
was found to contain a number of known and unidentified 
sterols, but lathosterol was not detected. Mean body 
weight (k SD) at the end of the high P/S diet was 
0.08 f 0.79 kg higher than at the end of the low P/S 
period. 
Blood samples were taken via the antecubital vein twice 
during the third week of each dietary period from fasting 
subjects. Portions of serum from these two samples were 
mixed and used for determination of serum cholesterol, 
lathosterol, and free methylsterol levels. Feces were col- 
lected during the last 5 days of each period. Radio-opaque 
markers were taken orally by the subjects (20/day from 10 
days before until the end of each fecal collection period), 
and the recovery of these was used to correct for variations 
in fecal flow, as described (20). The stools were frozen as 
Campesterol (mdday 1 65 35 
(mdday) 47 22 Stigmasterol were (means f SD): age 34 f 13 yr, height 178 f 9 cm, 
Lathosterol not detectable 
Q Includes Calculated contribution of free-choice items to macronutrient 
and cholesterol intake (16). 
'One MJ equals 239 Kcal. 
'Mainly ,inoleic acid, 
soon as possible after being passed, and stored at -2OOC. 
At the end of the experiment, the fecal collections from 
each person were combined per diet period, homogenized, 
The second part of the study consisted in determining 
lathosterol and cholesterol concentrations in the fasting 
serum of 20 patients heterozygous for familial hypercho- 
lesterolemia (FH) before and 1 and 6 months after start- 
ing treatment with the HMG-CoA reductase inhibitor 
Mk-733. These patients took part in an earlier clinical 
trial with this drug (21). In the present study they received 
20 mg of the drug per day during the first two days and 
40 mg per day during the next 5 months. Characteristics 
of these patients and effects of these treatment schedule on 
their serum (apo)lipoprotein levels are reported elsewhere 
(22). 
Analytical techniques 
Cholesterol and plant sterol contents of the consumed 
food (23) and the neutral steroid and bile contents of the 
feces (24) were determined by capillary gas-liquid chro- 
matography. Feces from each subject were analyzed in 
duplicate. In separate tests the coefficient of variation was 
about 2.5% for dietary cholesterol and less than 57% for 
the total amount of excreted neutral steroids and bile 
acids. The rate of whole-body cholesterol synthesis was 
calculated as the sum of the excreted endogenous steroids 
and bile acids minus the cholesterol intake (15, 16). 
Total (free plus esterified) serum cholesterol was deter- 
mined colorimetrically by the method of Abell et al. (25). 
Free cholesterol was assayed with a commercially availa- 
ble test kit (Boehringer Mannheim, cat. no. 310328). 
For the assay of total lathosterol, duplicate samples of 
200 pl serum were mixed each with 1 ml 0.3 M NaOH in 
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90% ethanol, and incubated for 60 min at 37OC. After 
addition of 1 ml distilled water, the nonsaponifiable lipids 
were extracted with 4 ml hexane. Campesterol (6.75 pg; 
Applied Sciences) was added as internal standard to each 
of the serum samples.* The nonsaponifiable lipids were 
converted into their trimethylsilyl ethers using Sil-Prep@ 
(Alltech Associates, Eke, Belgium). Lathosterol was quan- 
titated by gas-liquid chromatography, using a Packard 433 
chromatograph equipped with a 25 m x 0.22 mm (id.) 
fused silica capillary column with CP-Sil-5CB as the sta- 
tionary phase (Chrompack, Middelburg, The Nether- 
lands). Hydrogen was used as the carrier gas; the column 
was kept at a constant temperature of 235OC. Detection 
was by flame ionization. Response factors were assumed 
to be equal among the various steroids. Pure lathosterol 
(Steraloids, Wilton, NH) had a relative retention time of 
1.12 with respect to cholesterol and of 0.85 with respect to 
campesterol. The procedure was found to have an intra- 
assay coefficient of variation of 2% (n = 5). 
Free lanosterol and the sum of free methylsterols in 
serum were determined by a procedure modified from 
that described by Miettinen (4, 26). Analyses were carried 
out for a subset of 19 subjects from whom enough serum 
was available. Epicoprostanol(3 pg) was added as internal 
standard to 1 ml serum, and total lipids were extracted by 
the method of Folch, Lees, and Sloane Stanley (27). The 
extract was applied on a 20 x 20 cm thin-layer silica gel 
60 plate (Merck, West Germany, art. 5748), one sample 
per plate. To separate the various lipid classes, the plate 
was first developed in hexane-toluene 9O:lO (by vol), and 
then in heptane-diethyl ether 55:45 (by vol). Lipids were 
localized by spraying with Rhodamine. The free methyl- 
sterol band was scraped between the positions of choles- 
terol and a-tocopherol reference spots. The free methyl- 
sterols were eluted from the silica with diethyl ether, and 
the solvent was evaporated. Quantitation by gas-liquid 
chromatography was done as described above for latho- 
sterol, including prior derivatization into trimethylsilyl 
ethers. Free lanosterol (denoted as peak IV by Miettinen 
(4, 5)) was identified as such in serum extracts by mass 
spectrometry, and had a relative retention time of 1.81 
with respect to epicoprostanol. Other free methylsterols, 
denoted by Miettinen as peaks I, 111, 11, and V, respec- 
tively, had retention times of 1.52, 1.66, 1.77, and 1.92 
with respect to epicoprostanol. Repeated determinations 
on a pooled sample of human serum revealed intraassay 
coefficients of variation of 9% (n = 6) for free lanosterol. 
Statistical methods 
periods was evaluated by conventional methods (28). The 
95 % confidence intervals of the correlation coefficients 
were obtained using Fisher's Z-transformation. The 95% 
confidence intervals of the cholesterol balance (y) pre- 
dicted from the lathosterol/cholesterol ratio (x) were 
found using the formula 
I 
in which t(0.05;~-2) is the tabulated value at P = 0.05 
(two-tailed) and n-2 degrees of freedom (i.e., 2.15), and 
Z, n and C(xi - 2)' are obtained from the data of the 
diet study.' 
RESULTS 
Relation between cholesterol balance and 
serum lathosterol level 
This study was designed originally to document the 
effect of a change in dietary fatty acid composition on the 
rate of cholesterol synthesis. However, it is the purpose of 
the present study to focus on the serum levels of choles- 
terol precursors as indicators of cholesterol synthesis; the 
responses of serum sterols and cholesterol balance toward 
the change in dietary fatty acid composition will be de- 
scribed and discussed extensively elsewhere (Glatz, J. E C., 
and M. B. Katan, manuscript in preparation). Neverthe- 
less, it was deemed desirable to provide these levels in 
summary form, to be read only as background infor- 
mation. 
Table 2 lists the mean serum concentrations of 
cholesterol and lathosterol, the ratio of lathosterol over 
cholesterol, as well as the whole-body cholesterol balance, 
for the 47 participants in the third week of the two diet 
periods. For a subgroup of 19 persons, the serum levels of 
free cholesterol, free lanosterol, and sum of free methyl- 
sterols are also given. The mean values for serum sterols 
and for the cholesterol balance are in good agreement 
with those reported previously (1-5, 15, 16, 20) for adult 
humans on average Western diets. It is to be noted that 
the level of lathosterol is an order of magnitude higher 
than that of the free methylsterols. It is shown, further- 
more, that the levels of the various cholesterol precursors 
and the rate of whole-body cholesterol synthesis vary to a 
greater extent than the serum levels of cholesterol. 
The concentration of total lathosterol in serum cor- 
related very strongly with the cholesterol balance, both on 
Pearson correlation coefficients and linear regression 
parameters (slope, intercept, and standard error of the es- 
timate, denoted as a, b, and s, respectively, in the formula 
below) were calculated, and significance Of 
differences between these parameters for the two diet 
'The amount of campester01 present in 200 of five sera from each 
diet group was less than 1% of the amount of added campesterol. 
However, the use of another steroid not occurring in serum, such as 5a-  
cholestane, as internal standard is to be preferred. 
Kmpen et al. Serum lathosterol in humans 1151 
 at Vrije Universiteit, Library, Dept. of Electronic Resources on January 14, 2008 
w
w
w
.jlr.org
D
ow
nloaded from
 
TABLE 2. Mean levels of serum sterols and their ratios 
and the cholesterol balance" 
Total cholesterol (mmol/L) 
Free cholesterol (mmol/L) 
Total lathosterol (pmol/L) 
Lathosterol/cholesterol (pmollmmol) 
Free lanosterol (pmol/L) 
Sum of free methylsterols' (pmol/L) 
Free lanosterol/free cholesterol (pmollmmol) 
Sum of free methyl sterols/free cholesterol 
Cholesterol balance (mmol/day) 
(pmollmmol) 
5.53 k 1.04 
1.51 f 0.32 
5.32 + 2.05 
0.96 k 0.34 
0.30 f 0.11 
1.38 k 0.54 
0.20 + 0.06 
0.91 k 0.34 
1.69 k 0.78 
"Measured in the last week of a 3-week period of controlled feeding 
of a diet high (high P/S) or low (low P/S) in polyunsaturated fatty acids. 
Means k SD of 47 or, for serum free sterols, of 19 subjects. 
'Assumed to have a molecular weight of 400. 
the high PIS ( r  = 0.76; P < 0.001) and on the low PIS 
( r  = 0.73; P < 0.001) diet. However, a significant positive 
correlation was also observed between serum lathosterol 
and serum cholesterol for both diet periods ( r  = 0.34 for 
the high PIS and 0.29 for the low PIS diet, both P < 0.05). 
Therefore, lathosterol was adjusted for differences in total 
cholesterol by dividing the lathosterol concentration by 
the cholesterol concentration. As shown in Fig. 1, the 
lathosterollcholesterol ratio was still highly correlated 
with the cholesterol balance, with r = 0.74 for the high 
and 0.70 for the low PIS diet period. 
It has been reported before (29) that the rate of 
cholesterol synthesis correlates with body weight. This 
was confirmed in the present study: correlation coefficients 
of 0.56 (P < 0.001) existed between body weight and 
mean cholesterol balance at the end of the two diet 
periods. Nevertheless, even when the cholesterol balance 
was expressed per kg body weight, it correlated sig- 
nificantly with the lathosterollcholesterol ratio ( r  = 0.65 
. . . .. 
r=0.74 n=47 
I- 1 I 
d 1 2 t 4 
and r = 0.58, both P < 0.001, for the high PIS and low 
P/S period, respectively). 
It might seem from inspection of Fig. 1A and 1B that 
the relation between the lathosterollcholesterol ratio and 
the cholesterol balance was dissimilar in the two dietary 
situations. This was tested by comparing the slopes and 
intercepts of the regression lines obtained for the two diet 
periods. A t-value of 1.18 (P = 0.25) was calculated for the 
difference between slopes, and of -0.49 (P = 0.63) for the 
difference between intercepts (on the assumption of equal 
slopes; see ref. 28), which gives no support to the hypothe- 
sis that the regression lines are different. 
For the subgroup of 19 persons for whom the levels of 
lanosterol and free methylsterols were also quantitated, 
the lathosterollcholesterol ratio again correlated sig- 
nificantly with the cholesterol balance, but the free 
lanosterollfree cholesterol ratio and the free methyl- 
sterolslfree cholesterol ratio did not. The correlation 
coefficient for the lathosterollcholesterol ratio was sig- 
nificantly different from that for the free lanosterollfree 
cholesterol ratio (Table 3). 
Effect of Mk-733 on serum sterol levels 
In 20 patients heterozygous for familial hypercho- 
lesterolemia, treatment for 1 month with the cholesterol 
synthesis inhibitor Mk-733 lowered the level of cholesterol 
on average by 30% and that of lathosterol by 64%, so that 
the lathosterollcholesterol ratio fell by 47% (Table 4). 
These effects did not materially change during the next 5 
months of treatment. In a subset of 10 patients for whom 
serum free methylsterols were obtained as well, the 
lathosterol level tended to decrease more (by 54 rt 10%) 
than the level of free lanosterol (which fell by 42 rt 23%) 
after 1 month treatment, although the difference between 
these effects was not statistically significant. 
. I 
I J 
1 2 f 4 
i 
CHOLESTEROL BALANCE (mmoles/d) 
Fig. 1. Relationship between the lathosterol/cholesterol ratio in serum and the cholesterol balance in 47 subjects 
on a diet high (left-hand panel) or low (right-hand panel) in polyunsaturated fatty acids. The regression lines for 
cholesterol balance (Y) on lathosterol/cholesterol ratio (X) are: Y = 1.90 X - 0.08 (standard error of estimate 0.58) 
for the high PIS period, and Y = 1.50 X + 0.24 (standard error of estimate 0.60) for the low P/S period. 
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TABLE 3. Pearson correlation coefficients ( r ) ,  
and 95% confidence intervals (CI)” 
T 95% CI 
Total lathosterol/total cholesterol 0.663 0.435-0.811 
Free lanosterolffree cholesterol 0.052 - 0.282-0.374 
Sum of free methylsterols/free cholesterol 0.212 - 0.148-0.522 
“For the associations of cholesterol balance with the ratio total 
lathosterol/total cholesterol, the ratio free lanosterollfree cholesterol, or 
the ratio (sum of free methylsterols)/free cholesterol in 19 subjects on diets 
high or low in polyunsaturated fatty acids (data from both diet periods 
were used, yielding 38 pairs in each calculation). 
The 95% confidence interval for the rate of whole-body 
cholesterol synthesis was estimated in these patients from 
their mean lathosterol/cholesterol ratio. For that purpose, 
the slope, intercept, and standard error of the estimate, as 
found in the volunteer study, were substituted in equation 
1. This resulted in a prediction equation having the form: 
(X - 0.96)2 
y = 1 . 6 6 . ~  + 0.08 f 1.27 
6 
Accordingly, the predicted intervals for the whole-body 
cholesterol synthesis were 1.32-1.70 mmol/day before, and 
0.59-0.97 mmollday at 6 months after starting the 
Mk-733 medication. This indicates a statistically sig- 
nificant decrease in whole-body cholesterol synthesis. 
DISCUSSION 
The rationale for using the serum level of cholesterol 
precursors as an indicator for cholesterol synthesis lies in 
the assumption that these compounds in their unesterified 
form “leak” into plasma lipoproteins at a rate proportional 
to that of their formation in the cholesterol synthetic path- 
way. Only the unesterified methylsterols in serum are con- 
sidered to reflect cholesterol synthesis, since their esterifi- 
cation can only take place in the liver by ACAT (30) and 
not by LCAT in the plasma (31). Indeed, only the free And 
not the esterified methylsterols were found to vary with a 
diurnal rhythm (4). The amount of esterified methyl- 
sterols (which is less than 20% of the total (4)) has been 
proposed as an indicator of hepatic ACAT activity or 
VLDL secretion (32). In contrast, lathosterol was present 
for 50% or more in the esterified form (14, confirmed in 
our own laboratory) and probably is esterified by LCAT 
in the serum. For this reason, total rather than free 
lathosterol in serum may be expected to reflect “leakage” 
from cellular sterologenesis. 
Furthermore, Miettinen (3-5)  has advocated expression 
of the serum levels of precursors relative to the level of free 
or total cholesterol as a way to correct for differences in 
these levels that would occur as a mere consequence of a 
different number of acceptor (lipoprotein) particles in the 
serum compartment. We have followed this practice in 
this report, supported by the finding of a significant, 
although low, correlation between serum lathosterol and 
cholesterol levels. Division of the lathosterol values by the 
cholesterol concentrations did not, however, materially 
affect the high correlation coefficients with the cholesterol 
balance. 
The potential use of the serum level of lathosterol as in- 
dicator of the whole-body cholesterol synthesis was first 
discovered in a study with a relatively small number of 
patients, in which the actual rate of cholesterol synthesis 
was not determined (13). The present study, done with a 
large group of healthy volunteers on two different diets, 
shows directly that lathosterol and the lathosterokholes- 
terol ratio are indeed good monitors of whole-body cho- 
lesterol synthesis within the range of synthetic rates occur- 
ring in healthy people on normal Western diets, in a 
manner that is apparently independent of the fatty acid 
composition of the diet. To our knowledge, this capacity 
as an indicator has not been demonstrated for either 
methylsterols or mevalonate. 
Miettinen et al. (13, 14) observed that lathosterol 
changed in a more pronounced manner than free methyl- 
sterols upon manipulating the enterohepatic circulation. 
We add the following evidence that serum lathosterol is 
superior to serum free methylsterols as an indicator of 
cholesterol synthesis. First, in 19 participants of the diet 
study, the cholesterol balance correlated significantly 
better with the lathosterol/cholesterol ratio than with the 
free lanosterol/free cholesterol ratio (Table 3). Secondly, 
in a previous study of 41 subjects on diets high or low in 
dietary cholesterol (given as egg yolks) (15, 16) we found 
a low correlation ( r  = 0.30, P < 0.05) between the cho- 
TABLE 4. Serum levels (means i SD) of lathosterol and cholesterol in 20 patients with familial 
hypercholesterolemia before and during treatment with Mk-733 
One Month after Start Six Months after Start Before 
Lathosterol (pnol/L) 9.6 i 4.0 3.5 f 1.4 2.9 i 1.8 
Cholesterol (mmol/L) 11.3 * 1.9 7.9 1.3 7.0 i 1.4 
Latho/chol (pmol/mmol) 0.86 * 0.36 * 0.46 f 0.19 0.42 i 0.26 
* a  
“Significant difference between values on either side of the asterisk 
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lesterol balance and the serum level of free lanosterol 
during the low, but none at all during the high cholesterol 
period (Katan, M. B., A. C. Beynen, and C. M. van Gent, 
unpublished results). The  lack of correlation in the latter 
period might be related to the fact that egg yolks contain 
considerable amounts of lanosterol (350 f 30 Fg per egg 
yolk (n = 4); Kempen, H. J. M., and H .  A. van der 
Voort, unpublished observations), of which a fraction pos- 
sibly was absorbed. This factor may be involved in the 
present study as  well. In  contrast, lathosterol was not 
detected in the food in the present study. 
Serum lathosterol or the lathosterolkholesterol ratio 
are not only superior as indicators, but quantitation of 
total lathosterol is also considerably simpler than that of 
free methylsterols, due  mainly to the fact that the concen- 
tration of lathosterol is an  order of magnitude higher and 
a laborious sample workup using thin-layer chromatog- 
raphy is not required. Plasma mevalonate was recently 
proposed as a suitable indicator of cholesterolgenesis (8, 
9), but for its assay one has to resort to a relatively tedious 
radio-enzymatic procedure. 
The  lathosterol/cholesterol ratio was also measured in 
20 patients heterozygous for familial hypercholesterole- 
mia. The  mean value in these patients was not sig- 
nificantly different from that in the 47 volunteers in the 
diet study. This is in line with previous studies (33, 34) in 
which adult FH heterozygotes were found to have normal 
rates of cholesterol synthesis, as measured by more direct 
methods. Furthermore, upon treatment of these patients 
with the HMG-CoA reductase inhibitor Mk-733, the 
lathosterolkholesterol ratio dropped by about 50%. When 
the regression parameters found in the volunteer study 
were used to estimate the 95% confidence interval for the 
cholesterol balance in the patients before and on the drug, 
the drug caused a significant drop in the predicted value. 
This would be in contrast with a study by Grundy and 
Bilheimer (35) in which mevinolin did not lead to a sig- 
nificant decrease in cholesterol balance in five FH hetero- 
zygotes. I 
Addendum. After completion of this manuscript, Bjorkhem 
et al. (36) reported that serum levels of free methylsterols and of 
free and total lathosterol were all highly correlated with the 
hepatic HMG-CoA reductase activity in human patients sub- 
jected to gall bladder surgery. A reason why the values for the 
correlation coefficients were higher than found in our study may 
be that these workers included not only untreated patients but 
also patients pretreated with cholestyramine or with cheno- 
deoxycholic acid. This probably results in a much wider range 
of cholesterol synthetic rates than was the case in our group of 
volunteers. 
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